B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

R 406

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with R 406, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

fedratinib
228 shared targets
tae
223 shared targets
lestaurtinib
244 shared targets
kw
212 shared targets
su
183 shared targets
nintedanib
174 shared targets
tozasertib
166 shared targets
midostaurin
159 shared targets
bosutinib
152 shared targets
dovitinib
143 shared targets
Loading evidence profile...

This evidence profile for R 406 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.